PCVX Sale Disclosure
Wassil Jim · SEC Form 4 · Filed Sep 9, 2026
Sale
Calculated transaction value
$79.4K
Wassil Jim EVP, Chief Scientific Ofc, COO
PCVX
Vaxcyte
PCVX
Transaction date
Sep 9, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed same day
PCVX daily price context
Close on/before transaction
$59.51
Sep 9, 2026
Close before public filing
$60.36
Sep 8, 2026
Return since public filing
-3.69%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,334 shares @ $59.52
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001813798-26-000019
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$493.37K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vaxcyte, Inc. PCVX Current | Sale | Sep 9, 2026 | $79.4K |
| Vaxcyte, Inc. PCVX | Disposition | Sep 8, 2026 | $329.51K |
| Vaxcyte, Inc. PCVX | Sale | Sep 4, 2026 | $84.46K |